Literature DB >> 24131721

Residues Arg703, Asp777, and Arg781 of the RNase H domain of hepatitis B virus polymerase are critical for viral DNA synthesis.

Chunkyu Ko1, Youn-Chul Shin, Woo-Jin Park, Seungtaek Kim, Jonghwa Kim, Wang-Shick Ryu.   

Abstract

Hepatitis B virus (HBV) synthesizes its DNA genome through reverse transcription, which is catalyzed by viral polymerase (Pol). Previous studies suggested that the RNase H domain of hepadnaviral Pol may contribute to multiple steps of the viral genome replication, such as RNA encapsidation and viral DNA synthesis. However, specific residues of the RNase H domain that contribute to viral reverse transcription have not been determined. Therefore, we employed charged-to-alanine scanning mutagenesis to generate a set of single-substitution mutants of the RNase H domain and then analyzed their ability to support viral reverse transcription. Southern blot analysis showed that three mutants (R703A, D777A, and R781A mutants) yielded significantly reduced amounts of viral DNAs. However, none of these mutants were defective in RNA encapsidation. The data indicated that in the R703A and D777A mutants, minus-strand DNA synthesis was incomplete due to loss of catalytic activity of RNase H. In contrast, in the R781A mutant, the minus-strand DNA synthesis was near complete to some extent, while the plus-strand DNA synthesis (i.e., relaxed circular DNA) was severely impaired due to the defect in RNase H activity. Overall, our analysis revealed that three charged residues of the HBV Pol RNase H domain contribute to the catalysis of RNase H in removing the RNA template, but not in the RNA encapsidation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24131721      PMCID: PMC3911735          DOI: 10.1128/JVI.01916-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

1.  A novel cis-acting element facilitates minus-strand DNA synthesis during reverse transcription of the hepatitis B virus genome.

Authors:  Myeong-Kyun Shin; Jehan Lee; Wang-Shick Ryu
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

2.  Versatile PCR-mediated insertion or deletion mutagenesis.

Authors:  Jehan Lee; Hye-Jin Lee; Myeong-Kyun Shin; Wang-Shick Ryu
Journal:  Biotechniques       Date:  2004-03       Impact factor: 1.993

3.  cis-acting sequences required for encapsidation of duck hepatitis B virus pregenomic RNA.

Authors:  R C Hirsch; D D Loeb; J R Pollack; D Ganem
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

4.  Mutations affecting hepadnavirus plus-strand DNA synthesis dissociate primer cleavage from translocation and reveal the origin of linear viral DNA.

Authors:  S Staprans; D D Loeb; D Ganem
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

5.  Evidence that the 5'-end cap structure is essential for encapsidation of hepatitis B virus pregenomic RNA.

Authors:  J K Jeong; G S Yoon; W S Ryu
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

Review 6.  Mutational effects on protein stability.

Authors:  T Alber
Journal:  Annu Rev Biochem       Date:  1989       Impact factor: 23.643

7.  The P gene product of hepatitis B virus is required as a structural component for genomic RNA encapsidation.

Authors:  R Bartenschlager; M Junker-Niepmann; H Schaller
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

8.  Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli.

Authors:  F Galibert; E Mandart; F Fitoussi; P Tiollais; P Charnay
Journal:  Nature       Date:  1979-10-25       Impact factor: 49.962

9.  A short cis-acting sequence is required for hepatitis B virus pregenome encapsidation and sufficient for packaging of foreign RNA.

Authors:  M Junker-Niepmann; R Bartenschlager; H Schaller
Journal:  EMBO J       Date:  1990-10       Impact factor: 11.598

10.  Transcriptional regulation of hepatitis B virus by nuclear hormone receptors is a critical determinant of viral tropism.

Authors:  H Tang; A McLachlan
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-06       Impact factor: 11.205

View more
  12 in total

1.  Phosphoacceptors threonine 162 and serines 170 and 178 within the carboxyl-terminal RRRS/T motif of the hepatitis B virus core protein make multiple contributions to hepatitis B virus replication.

Authors:  Jaesung Jung; Seong Gyu Hwang; Yong-Joon Chwae; Sun Park; Ho-Joon Shin; Kyongmin Kim
Journal:  J Virol       Date:  2014-05-21       Impact factor: 5.103

2.  Purification and enzymatic characterization of the hepatitis B virus ribonuclease H, a new target for antiviral inhibitors.

Authors:  Juan Antonio Villa; Daniel P Pike; Kunjan B Patel; Elena Lomonosova; Gaofeng Lu; Roz Abdulqader; John E Tavis
Journal:  Antiviral Res       Date:  2016-06-17       Impact factor: 5.970

3.  Unveiling the roles of HBV polymerase for new antiviral strategies.

Authors:  Daniel N Clark; Jianming Hu
Journal:  Future Virol       Date:  2015       Impact factor: 1.831

4.  DDX3 DEAD-box RNA helicase is a host factor that restricts hepatitis B virus replication at the transcriptional level.

Authors:  Chunkyu Ko; Sooyoung Lee; Marc P Windisch; Wang-Shick Ryu
Journal:  J Virol       Date:  2014-09-17       Impact factor: 5.103

5.  DDB1 Stimulates Viral Transcription of Hepatitis B Virus via HBx-Independent Mechanisms.

Authors:  Woohyun Kim; Sooyoung Lee; Yeongnam Son; Chunkyu Ko; Wang-Shick Ryu
Journal:  J Virol       Date:  2016-10-14       Impact factor: 5.103

6.  Synergistic Interactions between Hepatitis B Virus RNase H Antagonists and Other Inhibitors.

Authors:  Elena Lomonosova; Adam Zlotnick; John E Tavis
Journal:  Antimicrob Agents Chemother       Date:  2017-02-23       Impact factor: 5.191

7.  Discovery and Selection of Hepatitis B Virus-Derived T Cell Epitopes for Global Immunotherapy Based on Viral Indispensability, Conservation, and HLA-Binding Strength.

Authors:  Monique T A de Beijer; Diahann T S L Jansen; Yingying Dou; Wim J E van Esch; Juk Yee Mok; Mariëlle J P Maas; Giso Brasser; Robert A de Man; Andrea M Woltman; Sonja I Buschow
Journal:  J Virol       Date:  2020-03-17       Impact factor: 5.103

8.  Hepatitis B virus genome recycling and de novo secondary infection events maintain stable cccDNA levels.

Authors:  Chunkyu Ko; Anindita Chakraborty; Wen-Min Chou; Julia Hasreiter; Jochen M Wettengel; Daniela Stadler; Romina Bester; Theresa Asen; Ke Zhang; Karin Wisskirchen; Jane A McKeating; Wang-Shick Ryu; Ulrike Protzer
Journal:  J Hepatol       Date:  2018-08-22       Impact factor: 25.083

9.  The Design and Development of a Multi-HBV Antigen Encoded in Chimpanzee Adenoviral and Modified Vaccinia Ankara Viral Vectors; A Novel Therapeutic Vaccine Strategy against HBV.

Authors:  Senthil K Chinnakannan; Tamsin N Cargill; Timothy A Donnison; M Azim Ansari; Sarah Sebastian; Lian Ni Lee; Claire Hutchings; Paul Klenerman; Mala K Maini; Tom Evans; Eleanor Barnes
Journal:  Vaccines (Basel)       Date:  2020-04-14

10.  The E3 Ubiquitin Ligase TRIM21 Promotes HBV DNA Polymerase Degradation.

Authors:  Ting Mu; Xiaoqing Zhao; Yanan Zhu; Hongxia Fan; Hua Tang
Journal:  Viruses       Date:  2020-03-21       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.